
Lantheus Holdings, Inc.
LNTHNasdaqCIK 1521036HealthcareFiscal year ends Dec 31
Reports and events: 225 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2207:30 ET | 8-K | 8.01 Other events | 0001193125-26-428324 |
| 2026-10-1416:30 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-421732 |
| 2026-10-0217:00 ET | 8-K | 8.01 Other events | 0001193125-26-412563 |
| 2026-09-2116:05 ET | 8-K | 8.01 Other events | 0001193125-26-396654 |
| 2026-09-0416:40 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-383754 |
| 2026-08-0608:01 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-336795 |
| 2026-08-0607:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-336771 |
| 2026-08-0421:00 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-331138 |
| 2026-08-0308:37 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-329622 |
| 2026-05-0707:44 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-210373 |
| 2026-05-0707:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-210369 |
| 2026-05-0116:30 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-201556 |
| 2026-03-2016:13 ET | DEF 14A | Proxy statementPeriod 2026-04-30 | 0001193125-26-117649 |
| 2026-02-2608:00 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-073498 |
| 2026-02-2607:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-073439 |
| 2025-11-1216:30 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-277754 |
| 2025-11-0607:48 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-268113 |
| 2025-11-0607:39 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-268103 |
| 2025-08-1117:02 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-25-178046 |
| 2025-08-0607:51 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-103544 |
| 2025-08-0607:39 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-103543 |
| 2025-07-2207:31 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-162233 |
| 2025-05-0707:41 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001628280-25-022872 |
| 2025-05-0707:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-022871 |
| 2025-05-0516:26 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-112812 |
| 2025-04-0109:12 ET | 8-K | 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-069927 |
| 2025-03-2117:23 ET | DEF 14A | Proxy statementPeriod 2025-05-01 | 0001193125-25-060360 |
| 2025-02-2607:56 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001628280-25-007970 |
| 2025-02-2607:42 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-007965 |
| 2025-01-3008:44 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-25-016381 |
| 2025-01-2806:23 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-013841 |
| 2025-01-1306:05 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-25-004904 |
| 2024-12-2316:32 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-284219 |
| 2024-12-1916:30 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-282047 |
| 2024-11-2006:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-262071 |
| 2024-11-0607:42 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001628280-24-045459 |
| 2024-11-0607:37 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045456 |
| 2024-09-2516:44 ET | 8-K | 7.01 Regulation FD disclosure | 0001193125-24-226113 |
| 2024-09-0508:38 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-213726 |
| 2024-07-3107:50 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001628280-24-033630 |
| 2024-07-3107:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-033629 |
| 2024-06-2707:14 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-169713 |
| 2024-06-2417:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-24-167026 |
| 2024-05-1516:43 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-139440 |
| 2024-05-0207:52 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001628280-24-019798 |
| 2024-05-0207:46 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-019794 |
| 2024-04-2916:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-122683 |
| 2024-03-1507:35 ET | DEF 14A | Proxy statementPeriod 2024-04-25 | 0001193125-24-068590 |
| 2024-02-2207:49 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001628280-24-006158 |
| 2024-02-2207:47 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-006157 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:54 ET. Listed shows no prices and gives no investment advice.